1.
Outcome of Combined Temozolomide/CCNU versus Temozolomide (Standard or Extended) For Patients with Methylated MGMT Glioblastoma. J. Can. Res. Updates. 2026;15(3):197-205. doi:10.30683/1929-2279.2026.15.18